Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Capital Leases (2020 - 2026)

Trulieve Cannabis has reported Capital Leases over the past 6 years, most recently at $64.1 million for Q4 2025.

  • For Q4 2025, Capital Leases fell 5.23% year-over-year to $64.1 million; the TTM value through Dec 2025 reached $64.1 million, down 5.23%, while the annual FY2025 figure was $64.1 million, 5.23% down from the prior year.
  • Capital Leases for Q4 2025 was $64.1 million at Trulieve Cannabis, down from $65.2 million in the prior quarter.
  • Over five years, Capital Leases peaked at $78.5 million in Q2 2022 and troughed at $38.1 million in Q1 2021.
  • A 5-year average of $64.5 million and a median of $65.2 million in 2021 define the central range for Capital Leases.
  • Biggest five-year swings in Capital Leases: surged 86.1% in 2021 and later decreased 17.64% in 2023.
  • Year by year, Capital Leases stood at $65.2 million in 2021, then increased by 7.21% to $69.9 million in 2022, then fell by 11.83% to $61.7 million in 2023, then rose by 9.73% to $67.7 million in 2024, then fell by 5.23% to $64.1 million in 2025.
  • Business Quant data shows Capital Leases for TCNNF at $64.1 million in Q4 2025, $65.2 million in Q3 2025, and $73.8 million in Q2 2025.